Cambridge Innovation Capital (CIC) is a venture fund based in Cambridge, United Kingdom, specializing in Seed, Series A, and Series B investments in BioTech, Healthcare, and Medical Device companies. Founded in 2013, CIC has made 71 investments and has seen 4 exits. Andrew Williamson is a key partner at CIC, and the fund is known for supporting life sciences and technology startups in the Cambridge ecosystem, often partnering with the university. One of their portfolio companies is Inivata. For more information, visit CIC's website at www.cic.vc or contact Andrew Williamson at andrew.williamson@cic.vc.